Undercarboxylated osteocalcin increases insulin sensitivity and secretion [27, 34–36], and serum levels of undercarboxylated osteocalcin negatively correlate with insulin resistance, obesity, and diabetes [7, 17, 37–39]. The gene discussed is INS; the disease is diabetes mellitus.